Effect of the South African asinine-94 strain of equine arteritis virus (EAV) in pregnant donkey mares and duration of maternal immunity in foals

dc.contributor.authorPaweska, Janusz Tadeusz
dc.contributor.editorVerwoerd, Daniel Wynand
dc.date.accessioned2017-06-29T06:53:04Z
dc.date.available2017-06-29T06:53:04Z
dc.date.created2012
dc.date.issued1997
dc.descriptionThe articles have been scanned in colour with a HP Scanjet 5590; 600dpi. Adobe Acrobat X Pro was used to OCR the text and also for the merging and conversion to the final presentation PDF-format.en_ZA
dc.description.abstractClinical, virological and serological responses were investigated in five pregnant donkey mares after experimental exposure to the South African asinine-94 strain of equine arteritis virus (EAV), and the duration of maternal immunity to EAV was studied in their foals. In four intranasally inoculated mares, fever with maximum rectal temperatures of 39,1-40,7°C was recorded 2-11 d after challenge. All the inoculated mares developed mild depression, and a serous ocular and nasal discharge; in three mares mild conjunctivitis was observed. The virus was recovered from the nasopharynx and from buffy-coat samples of all the mares 3-10 d, and 2-16 d post inoculation (p.i.), respectively. Seroconversion to EAV was detected on days 8- 10 p.i. Peak serum-virus- neutralizing antibody titres of log₁₀1,8-2,4, and lgG ELISA OD values of 0,85-2,15 were recorded 2-3 weeks p.i. The in-contact (p.c.) control mare developed fever on days 15-19 post exposure, and showed mild clinical signs of equine viral arteritis similar to those observed in the inoculated mares. Seroconversion to EAV was detected in the p.c. mare on day 20 post exposure, and virus was isolated from nasal swabs and blood samples collected at the time of the febrile response and 1-3 d afterwards. None of the mares aborted. After they had given normal birth 45-128 d p.i. or after p.c. exposure, no virus could be isolated from their placentas. The concentration of EAV-neutralizing antibody in colostrum was two to eight times higher than in serum samples collected at the time of parturition. All the foals born to infected mares were clinically normal at the time of birth and throughout the subsequent 1-2 months of observation. No EAV was recovered from the bully-coat fraction of blood samples collected at birth nor from those collected on days 1, 2 and 7 after birth. Also, no virus-serum- neutralizing or lgG ELISA antibody to EAV was detected in sera collected immediately after birth before the foals started nursing. The colostrum-derived maternal antibodies against EAV gradually declined and could not be detected by either the VN test or ELISA for 2-3 months after birth. This study demonstrates that the asinine-94 strain of EAV does not cause abortion in pregnant donkey mares. Furthermore, no carrier state could be demonstrated in foals born to mares infected at the time of pregnancy.en_ZA
dc.identifier.citationPaweska, JT 1997, 'Effect of the South African asinine-94 strain of equine arteritis virus (EAV) in pregnant donkey mares and duration of maternal immunity in foals’, Onderstepoort Journal of Veterinary Research, vol. 64, no. 2, pp. 147-152.en_ZA
dc.identifier.issn0330-2465
dc.identifier.urihttp://hdl.handle.net/2263/61214
dc.language.isoenen_ZA
dc.publisherPublished by the Agricultural Research Council, Onderstepoort Veterinary Instituteen_ZA
dc.rights© ARC-Onderstepoort (original). © University of Pretoria. Dept of Library Services (digital).en_ZA
dc.subjectVeterinary medicineen_ZA
dc.subject.lcshVeterinary medicine -- South Africa
dc.titleEffect of the South African asinine-94 strain of equine arteritis virus (EAV) in pregnant donkey mares and duration of maternal immunity in foalsen_ZA
dc.typeArticleen_ZA

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
21paweska1997.pdf
Size:
1.24 MB
Format:
Adobe Portable Document Format
Description:
Main article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: